As of 2025-07-04, the EV/EBITDA ratio of Corbus Pharmaceuticals Holdings Inc (CRBP) is -2.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRBP's latest enterprise value is 75.47 mil USD. CRBP's TTM EBITDA according to its financial statements is -33.47 mil USD. Dividing these 2 quantities gives us the above CRBP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-06-06 | -2.81 |
| 2025-06-05 | -2.65 |
| 2025-06-04 | -2.53 |
| 2025-06-03 | -2.47 |
| 2025-06-02 | -2.12 |
| 2025-05-30 | -2.15 |
| 2025-05-29 | -2.22 |
| 2025-05-28 | -2.08 |
| 2025-05-27 | -2.13 |
| 2025-05-23 | -2.14 |
| 2025-05-22 | -2.19 |
| 2025-05-21 | -2.15 |
| 2025-05-20 | -2.20 |
| 2025-05-19 | -2.27 |
| 2025-05-16 | -2.12 |
| 2025-05-15 | -2.07 |
| 2025-05-14 | -2.01 |
| 2025-05-13 | -2.09 |
| 2025-05-12 | -2.05 |
| 2025-05-09 | -1.79 |
| 2025-05-08 | -1.87 |
| 2025-05-07 | -1.68 |
| 2025-05-06 | -1.72 |
| 2025-05-05 | -2.15 |
| 2025-05-02 | -2.28 |
| 2025-05-01 | -2.19 |
| 2025-04-30 | -2.17 |
| 2025-04-29 | -2.07 |
| 2025-04-28 | -2.18 |
| 2025-04-25 | -2.39 |
| 2025-04-24 | -2.49 |
| 2025-04-23 | -2.14 |
| 2025-04-22 | -1.88 |
| 2025-04-21 | -1.74 |
| 2025-04-17 | -1.64 |
| 2025-04-16 | -1.60 |
| 2025-04-15 | -1.63 |
| 2025-04-14 | -1.56 |
| 2025-04-11 | -1.64 |
| 2025-04-10 | -1.52 |
| 2025-04-09 | -1.51 |
| 2025-04-08 | -1.41 |
| 2025-04-07 | -1.34 |
| 2025-04-04 | -1.27 |
| 2025-04-03 | -1.23 |
| 2025-04-02 | -1.34 |
| 2025-04-01 | -1.27 |
| 2025-03-31 | -1.38 |
| 2025-03-28 | -1.45 |
| 2025-03-27 | -1.55 |